Literature DB >> 17234904

Early detection of chronic pulmonary allograft dysfunction by exhaled biomarkers.

Alain Van Muylem1, Christiane Knoop, Marc Estenne.   

Abstract

RATIONALE: Early detection of bronchiolitis obliterans syndrome (BOS) is important because therapies are more likely to be effective if employed early in the disease process.
OBJECTIVES: To compare the performance of exhaled NO and CO (which reflect airway inflammation) and the slope of the alveolar plateau for helium (which reflects heterogeneity of ventilation distribution) for detection of BOS stages 0-p and 1.
METHODS: Recipients of bilateral (n=64) and single (n=1) lung grafts were prospectively monitored for 1,249 days; the helium slope was derived from single-breath washouts and exhaled NO and CO were measured by chemiluminescence on 933 occasions.
MEASUREMENTS AND MAIN RESULTS: At the end of follow-up, 9 patients were in stage 0-p and 16 patients were in BOS stage 1 or higher; 21 patients had at least one measurement made in BOS stage 0-p. All markers increased in BOS stage 0-p, but only the helium slope increased in BOS stage 1. The helium slope had better sensitivity for detection of stages 0-p and 1 than either exhaled NO or CO, but considering exhaled NO and CO together improved their sensitivity; the best sensitivity was found with the three markers in combination. The biomarkers had high negative predictive values, but low specificity and positive predictive values.
CONCLUSIONS: After lung transplantation, (1) the helium slope and exhaled NO, but also exhaled CO, increase in BOS stage 0-p, (2) the helium slope has better sensitivity than exhaled NO and CO for the detection of BOS stages 0-p and 1, and (3) exhaled biomarkers have high negative predictive values, but low specificity and positive predictive values.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17234904     DOI: 10.1164/rccm.200609-1301OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  13 in total

Review 1.  Immunosuppression and allograft rejection following lung transplantation: evidence to date.

Authors:  Gregory I Snell; Glen P Westall; Miranda A Paraskeva
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

Review 2.  Bronchoalveolar lavage and other methods to define the human respiratory tract milieu in health and disease.

Authors:  Herbert Y Reynolds
Journal:  Lung       Date:  2011-02-25       Impact factor: 2.584

3.  Serial monitoring of exhaled nitric oxide in lung transplant recipients.

Authors:  Mohamed A Gashouta; Christian A Merlo; Matthew R Pipeling; John F McDyer; J W Awori Hayanga; Jonathan B Orens; Reda E Girgis
Journal:  J Heart Lung Transplant       Date:  2014-11-06       Impact factor: 10.247

Review 4.  Carbon monoxide in exhaled breath testing and therapeutics.

Authors:  Stefan W Ryter; Augustine M K Choi
Journal:  J Breath Res       Date:  2013-02-27       Impact factor: 3.262

5.  Quality of recipient-caregiver relationship and psychological distress are correlates of self-care agency after lung transplantation.

Authors:  Annette DeVito Dabbs; Lauren Terhorst; Mi-Kyung Song; Diana A Shellmer; Jill Aubrecht; Mary Connolly; Mary Amanda Dew
Journal:  Clin Transplant       Date:  2012-09-24       Impact factor: 2.863

6.  Managing bronchiolitis obliterans syndrome (BOS) and chronic lung allograft dysfunction (CLAD) in children: what does the future hold?

Authors:  Gregory I Snell; Miranda Paraskeva; Glen P Westall
Journal:  Paediatr Drugs       Date:  2013-08       Impact factor: 3.022

7.  Evaluation of a hand-held, computer-based intervention to promote early self-care behaviors after lung transplant.

Authors:  Annette DeVito Dabbs; Mary Amanda Dew; Brad Myers; Alex Begey; Robert Hawkins; Dianxu Ren; Jacqueline Dunbar-Jacob; Erin Oconnell; Kenneth R McCurry
Journal:  Clin Transplant       Date:  2009-05-18       Impact factor: 2.863

Review 8.  Clinical application of exhaled nitric oxide measurement in pediatric lung diseases.

Authors:  Angelo Manna; Carlo Caffarelli; Margherita Varini; Carlotta Povesi Dascola; Silvia Montella; Marco Maglione; Francesco Sperlì; Francesca Santamaria
Journal:  Ital J Pediatr       Date:  2012-12-31       Impact factor: 2.638

9.  Prediction of BOS by the single-breath nitrogen test in double lung transplant recipients.

Authors:  Gerdt C Riise; Gunnar Mårtensson; Birgitta Houltz; Björn Bake
Journal:  BMC Res Notes       Date:  2011-11-26

10.  Exhaled nitric oxide in diagnosis and management of respiratory diseases.

Authors:  Abdullah A Abba
Journal:  Ann Thorac Med       Date:  2009-10       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.